바이오정보모아 (BioJungboMoa) — ADC · Antibody

8428프로그램 40FDA 승인

90오늘 방문

5,853누적 방문

7303갱신 대기 S–CData Tier S/A/B차세대 →Insight 1032HER2 breast 4683Antibody 2713CGT →Psoriasis →NSCLC 40FDA 승인

피드 Data Tier 차세대 Insight

CD19CART (CD19CART)

Leukemia, B-Cell; Lymphoma, B-Cell · CD19

#CD19#CGT#Preclinical#세포유전치료#CAR-T+5

임상시험 3상태 ACTIVE

ADCBiologicstaleSeagenPreclinical

Brentuximab vedotin plus chidamide (Consolidation therapy- 3 or 6 cycles of BvC, Consolidation therapy- 3 or 6 cycles of BvC(Brentuximab vedotin plus chidamide))

CD30+ Peripheral T-cell Lymphoma · CD30

#CD30#ADC#Preclinical#항체약물접합체#antibody-drug-conjugate+2

임상시험 3상태 RECRUITING

CGTBiologicstaleStephan Grupp MD PhDPhase 2

Murine CART19 (Murine CART19)

Pediatric and Young Adult Patientswith Hypodiploid or t(17;19) B-ALL; Infants With Very High Risk KMT2A B-ALL · Pediatric and Young Adult Patientswith H

함께 비교하는 진짜 ADC · Antibody · CGT 데이터

추천 비교

빠른 검색 · 이슈 태그

CD19CART (CD19CART)

Brentuximab vedotin plus chidamide (Consolidation therapy- 3 or 6 cycles of BvC, Consolidation therapy- 3 or 6 cycles of BvC(Brentuximab vedotin plus chidamide))

Murine CART19 (Murine CART19)

Second generation humanized CAR-T cells (Second generation humanized CAR-T cells)

OTL-200 Gene Therapy (OTL-200 Gene Therapy)

MB-CART19.1 Cellular Therapy (MB-CART19.1 Cellular Therapy)

Anti-TRBC1 CAR-T cells (Anti-TRBC1 CAR-T cells)

brentuximab vedotin (Adcetris, Brentuximab Vedotin, anti-PD-1 antibody.)

Gene Therapy product-MCO-010 (Gene Therapy product-MCO-010)

adeno-associated virus vector AAV- CNGA3 (adeno-associated virus vector AAV- CNGA3)

CARCIK-CD19 (CARCIK-CD19)

RS1 AAV Vector (RS1 AAV Vector)

AAV - CNGB3 (AAV - CNGB3)

Eque-cel CAR-T Therapy (Eque-cel CAR-T Therapy)

UCD19 CAR T Cells (UCD19 CAR T Cells)

Humanized CD7 CAR-T cells (Humanized CD7 CAR-T cells)

JCAR015 (JCAR015)

lovotibeglogene autotemcel (Lyfgenia, lovo-cel, bb1111)

Anti-CD123 CAR NK cells (Anti-CD123 CAR NK cells)

Adenosine A2B Receptor Antagonist PBF-1129 (Adenosine A2B Receptor Antagonist PBF-1129)

pembrolizumab (Keytruda, Coformulated vibostolimab/pembrolizumab)

Anti-CD19 UCAR-NK cells (Anti-CD19 UCAR-NK cells)

CAR-T cells targeting CD19 and CD22 (CAR-T cells targeting CD19 and CD22)

MEN1309 (MEN1309)

12-Day Production of Car-T Cells (12-Day Production of Car-T Cells)

함께 비교하는 진짜 ADC · Antibody · CGT 데이터

추천 비교

빠른 검색 · 이슈 태그

실시간 이슈 · 검색

CD19CART (CD19CART)

Brentuximab vedotin plus chidamide (Consolidation therapy- 3 or 6 cycles of BvC, Consolidation therapy- 3 or 6 cycles of BvC(Brentuximab vedotin plus chidamide))

Murine CART19 (Murine CART19)

Second generation humanized CAR-T cells (Second generation humanized CAR-T cells)

OTL-200 Gene Therapy (OTL-200 Gene Therapy)

MB-CART19.1 Cellular Therapy (MB-CART19.1 Cellular Therapy)

Anti-TRBC1 CAR-T cells (Anti-TRBC1 CAR-T cells)

brentuximab vedotin (Adcetris, Brentuximab Vedotin, anti-PD-1 antibody.)

Gene Therapy product-MCO-010 (Gene Therapy product-MCO-010)

adeno-associated virus vector AAV- CNGA3 (adeno-associated virus vector AAV- CNGA3)

CARCIK-CD19 (CARCIK-CD19)

RS1 AAV Vector (RS1 AAV Vector)

AAV - CNGB3 (AAV - CNGB3)

Eque-cel CAR-T Therapy (Eque-cel CAR-T Therapy)

UCD19 CAR T Cells (UCD19 CAR T Cells)

Humanized CD7 CAR-T cells (Humanized CD7 CAR-T cells)

JCAR015 (JCAR015)

lovotibeglogene autotemcel (Lyfgenia, lovo-cel, bb1111)

Anti-CD123 CAR NK cells (Anti-CD123 CAR NK cells)

Adenosine A2B Receptor Antagonist PBF-1129 (Adenosine A2B Receptor Antagonist PBF-1129)

pembrolizumab (Keytruda, Coformulated vibostolimab/pembrolizumab)

Anti-CD19 UCAR-NK cells (Anti-CD19 UCAR-NK cells)

CAR-T cells targeting CD19 and CD22 (CAR-T cells targeting CD19 and CD22)

MEN1309 (MEN1309)

12-Day Production of Car-T Cells (12-Day Production of Car-T Cells)

함께 비교하는 진짜 ADC · Antibody · CGT 데이터

추천 비교

빠른 검색 · 이슈 태그

실시간 이슈 · 검색

CD19CART (CD19CART)

Brentuximab vedotin plus chidamide (Consolidation therapy- 3 or 6 cycles of BvC, Consolidation therapy- 3 or 6 cycles of BvC(Brentuximab vedotin plus chidamide))

Murine CART19 (Murine CART19)

Second generation humanized CAR-T cells (Second generation humanized CAR-T cells)

OTL-200 Gene Therapy (OTL-200 Gene Therapy)

MB-CART19.1 Cellular Therapy (MB-CART19.1 Cellular Therapy)

Anti-TRBC1 CAR-T cells (Anti-TRBC1 CAR-T cells)

brentuximab vedotin (Adcetris, Brentuximab Vedotin, anti-PD-1 antibody.)

Gene Therapy product-MCO-010 (Gene Therapy product-MCO-010)

adeno-associated virus vector AAV- CNGA3 (adeno-associated virus vector AAV- CNGA3)

CARCIK-CD19 (CARCIK-CD19)

RS1 AAV Vector (RS1 AAV Vector)

AAV - CNGB3 (AAV - CNGB3)

Eque-cel CAR-T Therapy (Eque-cel CAR-T Therapy)

UCD19 CAR T Cells (UCD19 CAR T Cells)

Humanized CD7 CAR-T cells (Humanized CD7 CAR-T cells)

JCAR015 (JCAR015)

lovotibeglogene autotemcel (Lyfgenia, lovo-cel, bb1111)

Anti-CD123 CAR NK cells (Anti-CD123 CAR NK cells)